Intas Contributes two million tablets of hydroxychloroquine for Global Trials Against COVID-19 Medical Dialogues Bureau3 April 2020 4:45 AM GMTIntas will provide up to two million tablets of hydroxychloroquine to the trial, free of charge, along with two million tablets of matched placebo.
CDSCO issues regulatory pathway for R&D of IVD kit for diagnosis of COVID-19 Medical Dialogues Bureau24 March 2020 6:15 AM GMTDelhi: Through the recent notice Central Drugs Standard Control Organization(CDSCO), Directorate General of Health Services as apprised about the...
CDSCO to fast-track applications, issues regulatory pathway for R & D of drugs for COVID-19 Medical Dialogues Bureau22 March 2020 6:45 AM GMTDelhi: Through a recent notice Central Drugs Standard Control Organization(CDSCO) , Directorate General of Health Services has released the regulatory...
CDSCO updates procedure for issuance of WHO GMP Medical Dialogues Bureau15 March 2020 7:15 AM GMTNew Delhi: Through a recent notice Central Drugs Standard Control Organization (CDSC0), Directorate General of Health Services, has laid...
WHO warns of global shortage of medical equipment, surgical masks, protective gowns, gloves to fight coronavirus Medical Dialogues Bureau5 March 2020 9:44 AM GMTWashington: The World Health Organization (WHO) on Tuesday warned of a global shortage and price gouging for protective equipment to fight the...
Coronavirus: Restrictions imposed on the export of medical equipment to China Medical Dialogues Bureau24 Feb 2020 6:59 AM GMTNew Delhi: India said some restrictions were imposed on export of certain medical equipment to China in view of their short supply within the country...
Merck Ebola vaccine Ervebo to be available at lowest access price for poor nations Medical Dialogues Bureau24 Dec 2019 3:30 AM GMTThe vaccine, Ervebo, was approved by the U.S. Food and Drug Administration on Thursday, a month after Europe gave its nod to the vaccine, a move that...
Health Ministry, WHO join hands to redesignate NHSRC for development of medical devices Farhat Nasim4 Oct 2019 11:36 AM GMTThis year in collaboration with WHO's country office, NHSRC developed a guidance document for the health ministry's free diagnostics initiative to...
Cadila Pharma bags ObserveNow Future of Workplace Award among 50 others in fray Medical Dialogues Bureau16 Sep 2019 3:55 AM GMT"The selection was made on the basis of the technologies used in the company, HR policies, and initiatives taken to make the organization an...
Laurus Labs gets USFDA Establishment Inspection Report for Visakhapatnam units Medical Dialogues Bureau6 Sep 2019 7:33 AM GMTThe establishment inspection report (EIR) from US Food and Drug Administration (USFDA) is for company's active pharmaceutical ingredients units 1 and...
Bayer disagrees with German Government decision to ban Glyphosate from end of 2023 Medical Dialogues Bureau6 Sep 2019 3:30 AM GMT"Such a ban would ignore the overwhelming scientific assessments of competent authorities around the world that have determined for more than 40 years...
Zydus Cadila wins DCGI nod for marketing rabies drug Twinrab Medical Dialogues Bureau3 Sep 2019 4:30 AM GMT"The novel biologic which will be marketed under the brand name, Twinrab, is indicated in combination with rabies vaccine for rabies post-exposure...
